Activation of ras-dependent signaling pathways by G14-coupled receptors requires the adaptor protein TPR1

Somatostatin receptor expression in adrenocortical tumors and effect of a new somatostatin analog SOM230 on hormone secretion in vitro and in ex vivo adrenal cells

(2014) B. Mariniello et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Expression of Somatostatin Receptors in Human Melanoma Cell Lines: Effect of Two Different Somatostatin Analogues, Octreotide and SOM230, on Cell Proliferation

(2013) M Martinez-Alonso et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Gα16 interacts with tetratricopeptide repeat 1 (TPR1) through its β3 region to activate Ras independently of phospholipase Cβ signaling

(2011) Andrew MF Liu et al.   BMC STRUCTURAL BIOLOGY

Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multicenter French study

(2010) Eric Nguyen-Khac et al.   CANCER BIOLOGY & THERAPY

Gα16 activates Ras by forming a complex with tetratricopeptide repeat 1 (TPR1) and Son of Sevenless (SOS)

(2010) Andrew M.F. Liu et al.   CELLULAR SIGNALLING

Kinetic Scaffolding Mediated by a Phospholipase C-  and Gq Signaling Complex

(2010) G. L. Waldo et al.   SCIENCE

The antiproliferative effects of somatostatin receptor subtype 2 in breast cancer cells

(2009) Yong He et al.   ACTA PHARMACOLOGICA SINICA

Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice

(2009) Federica Barbieri et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

The RhoA-specific guanine nucleotide exchange factor p63RhoGEF binds to activated Gα16 and inhibits the canonical phospholipase Cβ pathway

(2009) Wendy W.S. Yeung et al.   CELLULAR SIGNALLING

Somatostatin Receptor Subtypes 2 and 5 Are Associated with Better Survival in Well-Differentiated Endocrine Carcinomas

(2008) Vito D. Corleto et al.   NEUROENDOCRINOLOGY

Somatostatin and somatostatin receptors in Cushing's disease

(2007) Leo J. Hofland   MOLECULAR AND CELLULAR ENDOCRINOLOGY